Key Highlights
- Tempus Next enhances clinician decision-making with AI to identify care gaps and offer real-time, actionable insights.
- Seamlessly integrates with EMRs, analyzing data across clinical notes, molecular info, and imaging.
- Now supporting oncology, specifically lung and breast cancer, following success in cardiology.
Source: Business Wire
Notable Quotes
- “The increasing complexity of guidelines…has created a growing number of care gaps. Next is designed to help close those gaps…” – Eric Lefkofsky, CEO and Founder at Tempus
- “This platform’s ability to notify us of care gaps and guide evidence-based decisions in real-time aligns perfectly with our mission…” – Andrew Parchman, MD, Precision Oncology Medical Director at TriHealth Cancer Institute
- “These insights enable timely adjustments to patient management, ensuring precision and responsive healthcare.” – Abhinav B. Chandra, MD, Medical Director at Yuma Regional
SoHC's Take
Tempus Next represents a significant advancement in the application of AI in healthcare, particularly in the fields of oncology and cardiology. By integrating deeply with existing medical records systems and utilizing a broad spectrum of data, it sets a new standard for proactive patient care. This approach not only helps bridge the existing care gaps but also ensures that healthcare providers can offer more personalized and effective treatments. As the platform expands into more areas and integrates further with healthcare practices, it could potentially transform the landscape of patient care by making precision medicine a common standard rather than an exception.
